10/18/16 - Tweaking the Immune Response Might be a Key to Combat Neurodegeneration
Study suggests zebrafish might teach us how to tackle Alzheimer’s disease. Research group led by Caghan Kizil at the DZNE report on these findings in the journal “Cell Reports”.
10/17/16 - ChemDiv, Torrey Pines Investment and DZNE Announce Research Collaboration
DZNE, ChemDiv, Inc. and Torrey Pines Investment jointly announced today an agreement initiating a Research and Development collaboration targeting pathways and molecular mechanisms underlying neurological health and disease.
10/06/16 - Researchers activate repair program for nerve fibers
Scientists of the DZNE have succeeded in releasing a molecular brake that prevents the regeneration of nerve connections. Researchers led by neurobiologist Frank Bradke report on these findings in the journal Neuron.
10/06/16 - Aberrant Tau Proteins Put Neuronal Networks to Sleep: Drug “Rolofylline” a Possible Antidote
The report which is based on laboratory studies suggests that the drug “Rolofylline” could possibly alleviate learning and memory problems associated with aggregating Tau proteins.
09/22/16 - United against Dementia among Children and Adults
Learning from each other, joint research and as such make new therapies against childhood and senile dementia more tangible – this is what the DZNE and the NCL Foundation, now want to push ahead.
09/20/16 - Alzheimer’s: Cellular Mechanism Provides Explanation Model for Declining Memory Performance
Loss of neuronal contacts impairs nerve cells that control activity of the hippocampus. Martin Fuhrmann and co-workers report on these findings in “Neuron”.
09/01/16 - Federal President Gauck visits German Center for Neurodegenerative Diseases
Today Joachim Gauck and his partner Daniela Schadt informed themself about the diverse research at DZNE.
06/09/16 - A New Biomarker for Nerve Cell Damage
Scientists at the German Center for Neurodegenerative Diseases (DZNE), the Hertie Institute for Clinical Brain Research and the University of Tübingen have identified proteins in the blood and cerebrospinal fluid that reflect ...
03/10/16 - UW-Madison delegation heads to DZNE in Germany for Alzheimer's, Dementia Research
A delegation of about a dozen UW-Madison research scientists will travel to Bonn and will share insights and information on the increasingly prevalent disease.
03/07/16 - DZNE and Orion Corporation start strategic collaboration
DZNE and Orion Corporation have agreed to start a strategic collaboration. They want to identify novel drug targets and develop treatments for neurodegenerative disorders.
02/17/16 - DZNE-research impacts German legislation
Scientific results of the DZNE-led study "Dementia Networks in Germany (DemNet-D)" were considered in a new German law to strengthen health care for people with dementia. This law enables statutory and private care insurance to ...
01/27/16 - Tübingen: DZNE Building for Brain Research opens under the auspices of Federal Research Minister Wanka, Science Minister Bauer and State Secretary Hofelich
High ranking representatives of politics and science inaugurated the new building for the DZNE on the grounds of the University Clinic Tübingen on January 27.
01/05/16 - Parkinson’s Disease: New Insights into a Traveling Protein
A laboratory study indicates that the main protein involved in Parkinson’s disease pathology does not behave as a ‘prion’ when overexpressed. Researchers led by Prof. Donato Di Monte report on this in the journal “BRAIN”.
12/18/15 - Magdeburg Brain Reseacher Emrah Düzel to coordinate the National Neuroimaging Network at the DZNE
So-called “Imaging techniques” are essential for understanding memory formation and cognition and the development of new therapies against brain diseases. The DZNE is now focusing its nationwide expertise in the field under the ...
12/17/15 - New insights into the molecular basis of memory
A DZNE study supports the hypothesis that memories are encoded with the help of chemical labels on the DNA. The findings are reported in „Nature Neuroscience“.
12/10/15 - DZNE Scientist Gets Most Important Research Award in Germany
The molecular biologist Frank Bradke, group leader at the DZNE and professor for neurobiology at the University of Bonn, will be awarded the “Gottfried Wilhelm Leibniz Prize”, which is endowed with 2.5 million euros.
11/24/15 - Science minister Hartmut Möllring inaugurates new MR-PET device
This morning, Saxony-Anhalt’s Minister of Science Hartmut Möllring inaugurated the new MR-PET device at the German Center for Neurodegenerative Diseases, site Magdeburg. The MR-PET device has opened up a whole new range of ...
11/23/15 - Laboratory study: Scientists from Cologne explore a new approach to prevent newborn epilepsies
Specific forms of epilepsy may manifest as early as in the first weeks of life. A new laboratory study shows that a preventive therapeutic strategy can be successful if it is applied within a time window critical to brain ...
11/16/15 - Fighting Parkinson's disease
The neurologist Michela Deleidi was successful in her application for a “Helmholtz Young Investigators Group”, after going through a competitive selection procedure. She will receive approximately 1.25 million Euros over the next ...
10/27/15 - Bonn Declaration of Open-Mindedness and Tolerance
10/08/15 - Experimental drug ameliorates symptoms of neurodegenerative brain disease in mice
In cooperation with colleagues in Munich and Göttingen, researchers at the DZNE in Bonn have analyzed a novel substance that could serve as a prototype for the development of drugs to treat Alzheimers and other brain diseases.
09/30/15 - Brain Researcher Monique Breteler appointed to the Royal Netherlands Academy
DZNE neuroepidemiologist honored for her research on dementia. The election recognizes her outstanding academic work and international scientific leadership.
09/17/15 - Cancer drug alleviates learning and memory problems in mice
Researchers in Göttingen have identified a cancer drug as a prototype drug that may be used to treat Alzheimer’s disease. This substance, known as “Vorinostat”, was found to alleviate learning and memory problems in mice.
08/31/15 - Overlooked for 30 years: a new kid on the block
A team led by Christian Haass has identified a novel peptide that plays a role in Alzheimer’s disease: The previously overlooked eta-amyloid interferes with neuronal function and may antogonize beta-amyloid – a finding that has ...
08/27/15 - Mystery of polar bear Knut’s disease finally solved
The polar bear suffered from an autoimmune disease of the brain. This non-infectious illness is called “anti-NMDA receptor encephalitis”, with symptoms in human patients similar to those displayed by Knut. Knut is the first wild ...